Skip to menu Skip to content Skip to footer
Professor Kiarash Khosrotehrani
Professor

Kiarash Khosrotehrani

Email: 
Phone: 
+61 7 344 37088

Overview

Background

Professor Khosrotehrani is a clinical scientist, dermatologist, interested in skin biology, regenerative medicine and skin cancer. He leads the Experimental Dermatology Group at the University of Queensland Diamantina Institute within the Translational Research Institute in Brisbane, Australia. He is also the deputy director of the Australian Skin and Skin Cancer Research Centre in Brisbane. Dr Khosrotehrani obtained his MD from the Cochin-Port Royal School of Medicine at René Descartes University, Paris, France, where he specialized in Dermatology. He is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) where he obtained a PhD in Physiology and Physiopathology. He is a fellow of the Australian College of Dermatologists and a practising dermatologist at the Princess Alexandra Hospital, Prince Charles Hospital and the Skin and Cancer Foundation’s Queensland Institute of Dermatology.

During his post-doctoral training at Tufts-New England Medical Center, Boston, USA, Dr. Khosrotehrani helped establish the contribution of fetal stem cells to tissue repair by demonstrating their multipotent capacity with a specific potency towards the endothelial lineage. The originality of this work was acknowledged by the NHMRC through an achievement award (2011) and an NHMRC excellence award (2016). He is currently a fellow of the NHMRC of Australia. The main focus of his laboratory is on regenerative medicine and stem cell biology in particular in injury response in skin wounds and skin cancer and how these responses contribute to cancer initiation and progression. Translating his laboratory findings, Dr Khosrotehrani is leading innovative clinical trials in wound healing, keratinocyte cancers and melanoma.

Availability

Professor Kiarash Khosrotehrani is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, University of Paris

Research interests

  • Tissue regeneration

    Endogenous response to injury. Vascular and Epithelial repair in response to ischemia or wounding. Hair follicle biology, cycling and regeneration.

  • Skin cancer

    Factors determining melanoma survival. Basal Cell carcinoma formation and progression Squamous cell carcinoma formation and UV irradiation

Works

Search Professor Kiarash Khosrotehrani’s works on UQ eSpace

331 works between 2001 and 2024

41 - 60 of 331 works

2023

Conference Publication

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

Hashemi, G., Sormani Le Bourhis, L., Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, May 12-13 2023. Oxford, United Kingdom: Elsevier.

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

2023

Journal Article

Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial

Cox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial. Journal of the European Academy of Dermatology and Venereology, 143 (5), S259-e975. doi: 10.1111/jdv.19041

Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial

2023

Journal Article

Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?

Bromfield, Jacoba Isobella, Hugenholtz, Philip, Frazer, Ian Hector, Khosrotehrani, Kiarash and Chandra, Janin (2023). Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?. Frontiers in Oncology, 13 1091379, 1091379. doi: 10.3389/fonc.2023.1091379

Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?

2023

Journal Article

Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study

Tedman, Alexander James, Liyanage, Upekha E., Chong, Sharene, Rowe, Casey, von Schuckmann, Lena A., Malt, Maryrose, Green, Adele C., Smithers, B. Mark and Khosrotehrani, Kiarash (2023). Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study. Australasian Journal of Dermatology, 64 (1), e34-e40. doi: 10.1111/ajd.13974

Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study

2023

Journal Article

Tribute to reviewers

Khosrotehrani, Kiarash and Schaider, Helmut (2023). Tribute to reviewers. Australasian Journal of Dermatology, 64 (1), 162-166. doi: 10.1111/ajd.13990

Tribute to reviewers

2023

Journal Article

Risk factors associated with first and second primary melanomas in a high-incidence population

Olsen, Catherine M., Pandeya, Nirmala, Dusingize, Jean Claude, Neale, Rachel E., MacGregor, Stuart, Law, Matthew H., Whiteman, David C., for the QSkin Study, Hayward, Nicholas K., Khosrotehrani, Kiarash and Gordon, Louisa G. (2023). Risk factors associated with first and second primary melanomas in a high-incidence population. JAMA Dermatology, 159 (1), 37-46. doi: 10.1001/jamadermatol.2022.4975

Risk factors associated with first and second primary melanomas in a high-incidence population

2022

Conference Publication

Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load

Wong, H., Lee, R., Roy, E., Kapadia, S., Murigneux, V., Chong, S., Freeman, M. and Khosrotehrani, K. (2022). Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load. 51st Annual ESDR Meeting, Amsterdam, Netherlands, 28 September-1 October 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2022.09.449

Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load

2022

Conference Publication

Variation in epidermal mutation burden after field treatment with topical 5-fluorouracil

Lee, R., Wong, H., Brown, S., Roy, E. and Khosrotehrani, K. (2022). Variation in epidermal mutation burden after field treatment with topical 5-fluorouracil. 51st Annual ESDR Meeting, Amsterdam, Netherlands, 28 September-1 October 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2022.09.504

Variation in epidermal mutation burden after field treatment with topical 5-fluorouracil

2022

Journal Article

Macrophages in skin wounds: functions and therapeutic potential

Sim, Seen Ling, Kumari, Snehlata, Kaur, Simranpreet and Khosrotehrani, Kiarash (2022). Macrophages in skin wounds: functions and therapeutic potential. Biomolecules, 12 (11) 1659, 1-31. doi: 10.3390/biom12111659

Macrophages in skin wounds: functions and therapeutic potential

2022

Journal Article

Melanoma tumour vascularization and tissue-resident endothelial progenitor cells

Hashemi, Ghazaleh, Dight, James, Khosrotehrani, Kiarash and Sormani, Laura (2022). Melanoma tumour vascularization and tissue-resident endothelial progenitor cells. Cancers, 14 (17) 4216, 1-23. doi: 10.3390/cancers14174216

Melanoma tumour vascularization and tissue-resident endothelial progenitor cells

2022

Journal Article

Skin biomechanics: a potential therapeutic intervention target to reduce scarring

Hosseini, Motaharesadat, Brown, Jason, Khosrotehrani, Kiarash, Bayat, Ardeshir and Shafiee, Abbas (2022). Skin biomechanics: a potential therapeutic intervention target to reduce scarring. Burns and Trauma, 10 tkac036, tkac036. doi: 10.1093/burnst/tkac036

Skin biomechanics: a potential therapeutic intervention target to reduce scarring

2022

Journal Article

Myeloid Wls expression is dispensable for skin wound healing and blood vessel regeneration

Sim, Seen Ling, Blumenthal, Antje, Kaur, Simranpreet and Khosrotehrani, Kiarash (2022). Myeloid Wls expression is dispensable for skin wound healing and blood vessel regeneration. Frontiers in Endocrinology, 13 957833, 957833. doi: 10.3389/fendo.2022.957833

Myeloid Wls expression is dispensable for skin wound healing and blood vessel regeneration

2022

Journal Article

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

Aung, Thazin Nwe, Shafi, Saba, Wilmott, James S., Nourmohammadi, Saeed, Vathiotis, Ioannis, Gavrielatou, Niki, Fernandez, Aileen, Yaghoobi, Vesal, Sinnberg, Tobias, Amaral, Teresa, Ikenberg, Kristian, Khosrotehrani, Kiarash, Osman, Iman, Acs, Balazs, Bai, Yalai, Martinez-Morilla, Sandra, Moutafi, Myrto, Thompson, John F., Scolyer, Richard A. and Rimm, David L. (2022). Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. eBioMedicine, 82 104143, 1-14. doi: 10.1016/j.ebiom.2022.104143

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

2022

Journal Article

High-yield isolation of pure fetal endothelial colony forming cells and mesenchymal stem cells from the human full-term placenta

Nano, Rachel, Sim, Seen Ling, Shafiee, Abbas, Khosrotehrani, Kiarash and Patel, Jatin (2022). High-yield isolation of pure fetal endothelial colony forming cells and mesenchymal stem cells from the human full-term placenta. STAR Protocols, 3 (2) 101354, 101354. doi: 10.1016/j.xpro.2022.101354

High-yield isolation of pure fetal endothelial colony forming cells and mesenchymal stem cells from the human full-term placenta

2022

Journal Article

Keratinocyte Cancer Mortality in Kidney Transplant Recipients

Shao, Emily Ximin, Betz-Stablein, Brigid, Khosrotehrani, Kiarash, Campbell, Scott, Isbel, Nicole and Green, Adele C. (2022). Keratinocyte Cancer Mortality in Kidney Transplant Recipients. Transplantation, 106 (5), 1078-1083. doi: 10.1097/tp.0000000000003827

Keratinocyte Cancer Mortality in Kidney Transplant Recipients

2022

Journal Article

Diet quality is associated with primary melanoma thickness

Hughes, M. C. B., Malt, M., Khosrotehrani, K., Smithers, B. M. and Green, A. C. (2022). Diet quality is associated with primary melanoma thickness. Journal of the European Academy of Dermatology and Venereology, 36 (10), 1745-1750. doi: 10.1111/jdv.18174

Diet quality is associated with primary melanoma thickness

2022

Journal Article

Pathways from diagnosis to death from keratinocyte cancer in kidney transplant recipients

Shao, Emily Ximin, Khosrotehrani, Kiarash, Campbell, Scott, Isbel, Nicole and Green, Adele (2022). Pathways from diagnosis to death from keratinocyte cancer in kidney transplant recipients. Dermatology, 238 (6), 1-8. doi: 10.1159/000524120

Pathways from diagnosis to death from keratinocyte cancer in kidney transplant recipients

2022

Journal Article

Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: a multi‐centre study

Clayton, Bethan, Muneeb, Ferhan, Hughes, Maria Celia B., Grant, Megan E., Khosrotehrani, Kiarash, Smithers, B. Mark, Spina, Romina, Campana, Luca G., Oudit, Deemesh and Green, Adele C. (2022). Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: a multi‐centre study. International Journal of Cancer, 151 (3), 396-401. doi: 10.1002/ijc.34020

Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: a multi‐centre study

2022

Journal Article

Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial

Chong, Sharene, Wong, Ho Yi, Althabteh, Ahmad, Cox, Charlotte, Stevenson, Paul H., Brown, Susan, Griffin, Anthony, Isbel, Nicole, Siller, Gregory, Soyer, H. Peter, Schaider, Helmut, Roy, Edwige, Campbell, Scott, Green, Adele C. and Khosrotehrani, Kiarash (2022). Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial. Journal of the American Academy of Dermatology, 87 (5), 1163-1166. doi: 10.1016/j.jaad.2022.02.039

Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial

2022

Journal Article

A murine Kitl allele regulates skin mast cell density across 58 collaborative mouse cross strains

Walker, Graeme J., Galbraith, Jack A., Baz, Betoul, Ferguson, Blake, Handoko, Herlina Y. and Khosrotehrani, Kiarash (2022). A murine Kitl allele regulates skin mast cell density across 58 collaborative mouse cross strains. Journal of Investigative Dermatology, 142 (8), 2275-2280.e4. doi: 10.1016/j.jid.2021.12.032

A murine Kitl allele regulates skin mast cell density across 58 collaborative mouse cross strains

Funding

Current funding

  • 2024 - 2026
    Targeting endothelial trans-differentiation in vascular lesions ((NHMRC Ideas Grant) administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2023 - 2026
    Molecular definition of cellular states in the vascular endothelium
    ARC Discovery Projects
    Open grant
  • 2022 - 2025
    PREDICT: PREcision DIagnostiCs for early melanoma detection using spaTial biology and AI-guided image analysis
    United States Congressionally Directed Medical Research Programs - Melanoma Research Program
    Open grant
  • 2022 - 2026
    Determining Causative Mechanisms of Hidradenitis Suppurativa (TRI LINC grant led by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2027
    The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2024
    Advanced technological approach to predicting survival in patients diagnosed with locally invasive cutaneous melanoma
    Cancer Council Queensland
    Open grant
  • 2021 - 2025
    Long-term protection in the growth restricted newborn
    Cerebral Palsy Alliance
    Open grant
  • 2020 - 2024
    QSKIN: the burden of skin cancer (NHMRC CTCS administered by QIMR Berghofer)
    Queensland Institute of Medical Research
    Open grant

Past funding

  • 2022 - 2023
    Manufacturing biological substitutes for wound healing and skin regeneration
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2023
    Reducing the burden of skin cancers through advanced chemoimmuno-prophylaxis
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2020 - 2022
    Molecular Targets in Endovascular Progenitors to Inhibit Lung and Skin Fibrosis in Scleroderma
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2019 - 2021
    Volumetric Modulated Arc Therapy (VMAT) Irradiation in Skin Cancer Incidence Prevention: A randomised, open-label, single arm, phase II, controlled trial (the Trial)
    Genesis Care Cancer Care Research Pty Ltd
    Open grant
  • 2019 - 2022
    Potency and activity of Meso-Endothelial bipotent progenitors in vivo
    ARC Discovery Projects
    Open grant
  • 2019 - 2022
    Targeting the pre-metastatic vascular niche in melanoma using a novel molecular strategy
    NHMRC Project Grant
    Open grant
  • 2018 - 2019
    Systems Biology of the skin
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    Improving brain outcomes in the growth restricted newborn using placental stem cell treatment
    Financial Markets Foundation for Children
    Open grant
  • 2018 - 2021
    Fighting epidermal skin cancers by targeting epidermal clones that accumulate mutations
    NHMRC Project Grant
    Open grant
  • 2018 - 2020
    Improved antigen-specific immunotherapy for cutaneous malignant melanoma
    Cancer Council Queensland
    Open grant
  • 2018 - 2021
    Stem cell treatment for neonatal hypoxic ischaemic encephalopathy
    NHMRC Project Grant
    Open grant
  • 2018
    Targeted and personalised early detection of melanoma using a 3D teledermatology network
    PA Research Foundation
    Open grant
  • 2017 - 2018
    Cutting-edge Imaging System for the Early Diagnosis of Face and Scalp Skin Cancer
    The Honda Foundation
    Open grant
  • 2017 - 2020
    Improving brain oxygen levels in babies using stem cell treatment
    The Children's Hospital Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Khosrotehrani
    Meehan Bequest
    Open grant
  • 2017 - 2020
    Modulating skin regenerative responses to improve wound repair and fight carcinogenesis
    NHMRC Career Development Fellowship
    Open grant
  • 2017 - 2019
    Predictors of mortality in thin melanomas
    Cancer Council Queensland
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Translational dermatology in skin and skin cancer research
    UQ Fellowships
    Open grant
  • 2015 - 2017
    The natural history of skin cancer formation: from normal skin to cancer
    Leo Foundation
    Open grant
  • 2015 - 2018
    Preventing basal cell carcinoma formation by targeting the tumour environment
    Leo Foundation
    Open grant
  • 2015
    Laser doppler perfusion imaging (LDPI) of revascularisation sites following vascular stem cell therapy
    RL Cooper Medical Research Foundation Limited
    Open grant
  • 2015 - 2017
    Role of resident endothelial progenitor cells in melanoma vascularisation and progression
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Systems analysis of epidermal biology and cancer (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2014
    Anti-inflammatory strategies to promote healing of chronic diabetic wounds
    Diabetes Australia Research Trust
    Open grant
  • 2013 - 2014
    Targeting the dermal component of basal cell carcinoma
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    A genome wide approach to identify important genetic determinants of skin wound healing
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2013 - 2016
    Innovations in Diabetic Foot Ulcer (DFU) Wound Care (NHMRC Project Grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2013
    Modelling mechanisms of drug responses in infantile haemangiomas (IH) by using placental endothelial progenitor cells (EPC)
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2013 - 2015
    Tracking epidermal clonal evolution during skin cancer induction and progression
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Understanding potency and role of individual stem cells in the skin using Rainbow technology
    ARC Discovery Projects
    Open grant
  • 2012 - 2014
    Fetal endothelial progenitors from the placenta as a source for cell therapy
    NHMRC Project Grant
    Open grant
  • 2012
    Multi-user in vivo and ex vivo tissue-level mechanical testing instrument for bone and stem cell research
    NHMRC Equipment Grant
    Open grant
  • 2012 - 2015
    NHMRC Career Development Fellowship (Clinical; Level 1): Stem and progenitor cell contribution to skin wounds and homeostasis
    NHMRC Career Development Award
    Open grant
  • 2012
    Tandem fluorescent and phase-contrast imaging of live cells in real time for application to cancer cell biology, developmental biology, respiratory biology, wound healing investigation and cellular to
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Routine assay to determine response to Braf inhibition therapy in melanoma
    UQ Collaboration and Industry Engagement Fund
    Open grant
  • 2011 - 2012
    Role of maternofetal chimerism in transferring susceptibility to MS
    National Multiple Sclerosis Society-US
    Open grant
  • 2011 - 2013
    Development of the routine assay to determine response to Braf inhibition therapy in melanomas
    UQ FirstLink Scheme
    Open grant
  • 2011
    Molecular markers to predict sentinel lymph node invasion and 5-year and 10-year outcomes in patients with stage I and II primary melanoma
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2011
    Persisting host dermal and epidermal antigen presenting cells as predictors of chronic graft versus host disease
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2011
    Predictive value of STAT5 activity in melanoma metastasis and survival
    Royal Brisbane and Women's Hospital
    Open grant
  • 2010
    Macroscopic fluorescence imaging system for identifying and isolating transgenically tagged cells
    NHMRC Equipment Grant
    Open grant
  • 2010
    Multi-user small animal digital x-ray imaging machine for bone, cancer, inflammation and stem cell research
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Preclinical optimisation of intrauterine transplantation of fetal mesenchymal stem cells for osteogenesis imperfecta.
    NHMRC Project Grant
    Open grant
  • 2009 - 2010
    Influence of dermal fibroblasts on epidermal stem cell homeostasis in a model of ageing
    Ramaciotti Foundation
    Open grant
  • 2009
    High-end optical in vivo molecular imaging system for stem cells, tumours, tissue repair and pathogens
    UQ School/Centre Co-Funding
    Open grant

Supervision

Availability

Professor Kiarash Khosrotehrani is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding and targeting determinants of mortality from melanoma

    Principal Advisor

    Other advisors: Dr Lena Von Schuckmann

  • Doctor Philosophy

    Mechanisms of Vascular Remodelling in Melanoma

    Principal Advisor

    Other advisors: Ms Laura Sormani Le Bourhis

  • Master Philosophy

    Understanding the mechanisms for increased mortality risk for pregnancy-associated melanoma.

    Principal Advisor

    Other advisors: Dr Brigid Betz-Stablein, Ms Laura Sormani Le Bourhis

  • Master Philosophy

    Anatomical Distribution and Immunoprevention of Keratinocyte Carcinoma

    Principal Advisor

  • Doctor Philosophy

    predicting melanoma survival using advanced digital imaging technologies

    Principal Advisor

    Other advisors: Dr Quan Nguyen

  • Master Philosophy

    Antibody mediated exacerbation of Pseudomonas aeruginosa infected chronic wounds

    Associate Advisor

    Other advisors: Dr Timothy Wells

  • Doctor Philosophy

    Understanding immune diversity in skin inflammation

    Associate Advisor

    Other advisors: Professor Gabrielle Belz, Dr Snehlata Kumari

  • Master Philosophy

    Evaluating the impact of social determinants of health on melanoma outcomes

    Associate Advisor

    Other advisors: Professor Annette Dobson, Dr Lena Von Schuckmann

  • Doctor Philosophy

    Understanding Melanoma Vascularisation to prevent metastasis

    Associate Advisor

    Other advisors: Ms Laura Sormani Le Bourhis

  • Doctor Philosophy

    Predictive and prognostic biomarkers for melanoma progression (BioMEL)

    Associate Advisor

    Other advisors: Dr Mitchell Stark

  • Master Philosophy

    Evaluating the effects of chronic diseases and lifestyle on the risk of melanoma recurrence

    Associate Advisor

    Other advisors: Dr Lena Von Schuckmann

  • Doctor Philosophy

    Targeting epigenetic regulation to overcome immunotherapy resistance in cutaneous melanoma

    Associate Advisor

    Other advisors: Professor Nikolas Haass, Dr Abbas Shafiee, Associate Professor Jason Lee

  • Doctor Philosophy

    Elucidate the role of interferon signalling pathways in skin diseases

    Associate Advisor

    Other advisors: Associate Professor Fiona Simpson, Dr Snehlata Kumari

Completed supervision

Media

Enquiries

Contact Professor Kiarash Khosrotehrani directly for media enquiries about:

  • basal cell carcinoma
  • Dermatology
  • Fetal stem cells
  • Melanoma
  • Skin cancer
  • Skin wound healing
  • squamous cell carcinoma
  • Stem cells - fetal
  • Stem cells - skin wound healing

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au